Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway.
about
Next-generation sequencing methylation profiling of subjects with obesity identifies novel gene changes.Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosisThe interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.IRAK4 deficiency promotes cardiac remodeling induced by pressure overload.C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and DysfunctionThe ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.Vinexin β Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor κB Inflammatory Axis.Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses.Vinexin family (SORBS) proteins play different roles in stiffness-sensing and contractile force generation.Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.Vinexin-β deficiency protects against cerebral ischaemia/reperfusion injury by inhibiting neuronal apoptosis.Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction.Vinexin family (SORBS) proteins regulate mechanotransduction in mesenchymal stem cellsEmergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
P2860
Q30008893-DCD46C51-2304-4AC1-BA80-32C242100922Q35846211-61AD6B6A-8E28-48AB-B4CA-0552B540A486Q36342106-7A1371AE-C43C-4614-BF6F-208591059CCFQ36492742-A5F71D16-DE21-4C5B-AA03-A595A44078CBQ36956778-DB74602A-7164-4677-8547-C9BA4663C094Q36974840-4AFA8B5B-6E66-4DAA-8763-A5D2A7E38B9EQ38956523-42E5DCA1-48CA-404A-8217-41C7C9C7AEA3Q38972944-7E4175CA-AB88-4172-88EC-0F47E77E8B6DQ40435871-A2A3BC1C-5357-4BE9-91DA-2657D3E4FB28Q41333298-C7C74830-B3F6-48E0-A1C2-7FFDD568E7D6Q41469937-CA76319E-3B64-4C09-9A23-77FA62962022Q47726123-FDED4C22-43CE-4F18-B2AC-64832A4E630DQ47924477-87DC6D98-C473-4092-8731-6081C627F23EQ48254695-6B8C141F-250E-4A54-BC39-FA8AD15E828AQ54168051-7BB2396B-C39D-46B1-BAFB-24883CB46995Q58449670-F9582D57-DC59-4AE5-A810-332F969C75A4Q58728912-C86FC117-B5A1-4329-B237-392DAB061DAD
P2860
Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Vinexin-β protects against car ...... -dependent signalling pathway.
@en
type
label
Vinexin-β protects against car ...... -dependent signalling pathway.
@en
prefLabel
Vinexin-β protects against car ...... -dependent signalling pathway.
@en
P2093
P2860
P1476
Vinexin-β protects against car ...... -dependent signalling pathway.
@en
P2093
Ding-Sheng Jiang
Hongliang Li
Noriyuki Kioka
Qinglin Yang
Xiao-Dong Zhang
Xue Hai Zhu
P2860
P2888
P356
10.1007/S00395-013-0338-0
P577
2013-02-22T00:00:00Z
P6179
1001249751